3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Ketosis
1
Insulin Resistance
1
Glioma
1
Glioblastoma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Cisplatin
509
Cyclophosphamide
360
Carboplatin
352
Radiotherapy
350
Capecitabine
329
Paclitaxel
325
Oxaliplatin
324
Gemcitabine
319
Docetaxel
311
Fluorouracil
283
Drug Therapy
243
apatinib
242
Bevacizumab
229
camrelizumab
214
Etoposide
200
Irinotecan
176
Doxorubicin
175
Leucovorin
161
Dexamethasone
160
sintilimab
142
pembrolizumab
138
anlotinib
136
Pemetrexed
136
Cytarabine
136
toripalimab
129
Neoadjuvant Therapy
122
S 1 (combination)
120
Vincristine
119
Rituximab
117
Radiosurgery
117
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Interventional
×
Hypoglycemic Agents
×
Clear all
NCT02149459
2017-10-27
SMC 0712-13
Sheba Medical Center
Phase 1
Unknown
18 enrolled